Matches in Nanopublications for { ?s ?p "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP265058.RAUTIaqINYYMN5C3ZF0UNx1O9uZnAK87prEwjf9KYF4kk130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265058.RAUTIaqINYYMN5C3ZF0UNx1O9uZnAK87prEwjf9KYF4kk130_provenance.
- NP524717.RAanUCqg4LCUHlHC2EdglLJYIqFy2zZjiPs8xA9SPk8PY130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524717.RAanUCqg4LCUHlHC2EdglLJYIqFy2zZjiPs8xA9SPk8PY130_provenance.
- NP807590.RADkP14bO3E4qzEyZXozntfChyo0WEvtc6Jil3FD7pNdo130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807590.RADkP14bO3E4qzEyZXozntfChyo0WEvtc6Jil3FD7pNdo130_provenance.
- NP486649.RAr15Ryew2pZ6PhWXIOJw-Gtt5YNu85hMM2f9YaTd6OkQ130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486649.RAr15Ryew2pZ6PhWXIOJw-Gtt5YNu85hMM2f9YaTd6OkQ130_provenance.
- NP779709.RAXOxxfoB1jjb48L9PRNvTYWgKmHUlzf_T6oX8vNiJdkI130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779709.RAXOxxfoB1jjb48L9PRNvTYWgKmHUlzf_T6oX8vNiJdkI130_provenance.
- NP299738.RAFzJ2Y34gK41AkVDDMWc9SWRpAYXbwKX7aWcWyApf3Ls130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299738.RAFzJ2Y34gK41AkVDDMWc9SWRpAYXbwKX7aWcWyApf3Ls130_provenance.
- NP769805.RAxQ5Zx3DsJqdVZSW3moTRmlw5MA9ry4AYFZp7Ttst4LA130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769805.RAxQ5Zx3DsJqdVZSW3moTRmlw5MA9ry4AYFZp7Ttst4LA130_provenance.
- NP683570.RA8vRA08uTKV8Zl4_8HobxhrZAyjhAyTc_YCFX4xUzJys130_assertion description "[Two are caused by reduced synthesis/availability of PLP (Pyridox(am)in-phosphate oxidase (PNPO) deficiency and infantile hypophosphatasia) and two by increased utilization/inactivation (pyridoxine-dependent epilepsy and hyperprolinemia type II).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683570.RA8vRA08uTKV8Zl4_8HobxhrZAyjhAyTc_YCFX4xUzJys130_provenance.